candesartan cilexetil has been researched along with Reperfusion Injury in 4 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In human umbilical endothelial cells, candesartan increased the eNOS protein level AT2-R dependently, inhibited the expression of nicotinamide adenine dinucleotide phosphate oxidase subunits and angiotensin II-induced intracellular reactive oxygen species and nitric oxide, and promoted the extracellular release of nitric oxide, suggesting that it augmented the bioavailability of nitric oxide." | 1.35 | Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies. ( Kanematsu, Y; Kinouchi, T; Kitazato, KT; Liu, H; Nagahiro, S; Tada, Y; Tamura, T; Uno, M; Yagi, K, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lapi, D | 1 |
| Cammalleri, M | 1 |
| Dal Monte, M | 1 |
| Di Maro, M | 1 |
| Santillo, M | 1 |
| Belfiore, A | 1 |
| Nasti, G | 1 |
| Damiano, S | 1 |
| Trio, R | 1 |
| Chiurazzi, M | 1 |
| De Conno, B | 1 |
| Serao, N | 1 |
| Mondola, P | 1 |
| Colantuoni, A | 1 |
| Guida, B | 1 |
| Liu, H | 1 |
| Kitazato, KT | 1 |
| Uno, M | 1 |
| Yagi, K | 1 |
| Kanematsu, Y | 1 |
| Tamura, T | 1 |
| Tada, Y | 1 |
| Kinouchi, T | 1 |
| Nagahiro, S | 1 |
| Araya, J | 2 |
| Tsuruma, T | 2 |
| Hirata, K | 2 |
| Yagihashi, A | 2 |
| Meguro, M | 1 |
| Kawakami, M | 1 |
| Yanai, Y | 1 |
| Watanabe, N | 2 |
4 other studies available for candesartan cilexetil and Reperfusion Injury
| Article | Year |
|---|---|
The Effects of Angiotensin II or Angiotensin 1-7 on Rat Pial Microcirculation during Hypoperfusion and Reperfusion Injury: Role of Redox Stress.
Topics: Angiotensin I; Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Female; Male; Microcircu | 2021 |
Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Brain Ischemia | 2008 |
The regulation of HGF and TGF-beta by an angiotensin II type 1 receptor antagonist in hepatic ischemia-reperfusion injury.
Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Enzyme-Linked Immunos | 2003 |
TCV-116, an angiotensin II type 1 receptor antagonist, reduces hepatic ischemia-reperfusion injury in rats.
Topics: Alanine Transaminase; Angiotensin Receptor Antagonists; Animals; Aspartate Aminotransferases; Benzim | 2002 |